Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
Kathryn Banfill, Meredith Giuliani, M.C. Aznar, et al.
Journal of Thoracic Oncology (2020) Vol. 16, Iss. 2, pp. 216-227
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4229-4361
Open Access | Times Cited: 1556
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal - Cardiovascular Imaging (2022) Vol. 23, Iss. 10, pp. e333-e465
Open Access | Times Cited: 210
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): an open-label, randomised, phase 3 trial
C. Le Péchoux, N. Pourel, Fabrice Barlési, et al.
The Lancet Oncology (2021) Vol. 23, Iss. 1, pp. 104-114
Closed Access | Times Cited: 186
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects
Shengjie Tang, Chao Qin, Haiyang Hu, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 320-320
Open Access | Times Cited: 130
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Demystifying the Results of RTOG 0617: Identification of Dose Sensitive Cardiac Subregions Associated With Overall Survival
A. McWilliam, A. Abravan, Kathryn Banfill, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 5, pp. 599-607
Open Access | Times Cited: 50
Non-small-cell lung cancer
Lizza E.L. Hendriks, Jordi Remón, C. Faivre‐Finn, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 37
Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung Cancer
Kyung Hwan Kim, Jaewon Oh, Gowoon Yang, et al.
JAMA Oncology (2022) Vol. 8, Iss. 11, pp. 1624-1624
Open Access | Times Cited: 57
Systemic and Radiation Therapy Approaches for Locally Advanced Non–Small-Cell Lung Cancer
Kristin Higgins, Sonam Puri, Jhanelle E. Gray
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 576-585
Closed Access | Times Cited: 39
An overview of chemotoxicity and radiation toxicity in cancer therapy
Victor Yazbeck, Erin R. Alesi, Jennifer S. Myers, et al.
Advances in cancer research (2022), pp. 1-27
Closed Access | Times Cited: 39
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer
Biniam Kidane, Matthew J. Bott, Jonathan Spicer, et al.
Journal of Thoracic and Cardiovascular Surgery (2023) Vol. 166, Iss. 3, pp. 637-654
Closed Access | Times Cited: 30
Selective Personalized RadioImmunotherapy for Locally Advanced Non–Small-Cell Lung Cancer Trial (SPRINT)
Nitin Ohri, Shruti Jolly, Benjamin T. Cooper, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 5, pp. 562-570
Closed Access | Times Cited: 26
Radiation Treatment Mechanisms of Cardiotoxicity: A Systematic Review
Konstantinos C. Siaravas, Christos S. Katsouras, Chrissa Sioka
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6272-6272
Open Access | Times Cited: 24
Open-source, fully-automated hybrid cardiac substructure segmentation: development and optimisation
Robert Finnegan, Vicky Chin, Phillip Chlap, et al.
Physical and Engineering Sciences in Medicine (2023) Vol. 46, Iss. 1, pp. 377-393
Open Access | Times Cited: 21
Current and Future Treatment Options in the Management of Stage III NSCLC
Yuchen Li, Rosalyn A. Juergens, Christian Finley, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 11, pp. 1478-1491
Open Access | Times Cited: 19
Indications and Parameters Around Postoperative Radiation Therapy for Lung Cancer
Antonin Lévy, Olaf Mercier, C. Le Péchoux
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 556-566
Closed Access | Times Cited: 27
Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study
Gareth Price, Sarah Devaney, David French, et al.
Clinical Oncology (2022) Vol. 34, Iss. 6, pp. 407-410
Open Access | Times Cited: 25
Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
Ladislav Baťalík, Kateřina Filáková, Ivana Radkovcova, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 25
Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans
Gerard M. Walls, Valentina Giacometti, Aditya Apte, et al.
Physics and Imaging in Radiation Oncology (2022) Vol. 23, pp. 118-126
Open Access | Times Cited: 22
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer
Melinda A. Pruis, G. Veerman, H. Carlijne Hassing, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 1, pp. 102-113
Open Access | Times Cited: 15
Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
James E. Bates, Suman Shrestha, Qi Liu, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 22, pp. 3826-3838
Closed Access | Times Cited: 13
Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study
Gerard M. Walls, John D. O’Connor, Mark Harbinson, et al.
Radiotherapy and Oncology (2023) Vol. 186, pp. 109762-109762
Open Access | Times Cited: 13
Engineering Stimuli‐Responsive Materials for Precision Medicine
Ruixuan Zheng, Yu Chang, Dan Yao, et al.
Small (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Should adolescents and young adults with Hodgkin lymphoma be treated as children or adults?
Lucille Lew‐Derivry, Florian Chevillon, Pauline Brice, et al.
British Journal of Haematology (2025)
Open Access
Page 1 - Next Page

Scroll to top